Skip to content

Brief Intervention for FCD: A Feasibility Study

Feasibility Pilot Study of a Brief Intervention in Functional Cognitive Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07379723
Enrollment
30
Registered
2026-01-30
Start date
2025-11-11
Completion date
2026-05-01
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Cognitive Disorder

Keywords

Functional Cognitive Disorder, Brief Interventions, Feasibility, Pilot, Attention Training

Brief summary

The goal of this study is to learn if a single session intervention for people with Functional Cognitive Disorder (FCD) is feasible and acceptable. The main questions it aims to answer are: What is the impact of a single session intervention on FCD symptoms, functional impairment, and quality of life in people with FCD? What is the feasibility and acceptability of piloting a single session intervention for people with FCD. Participants will: * Complete questionnaires about cognitive concerns, anxiety, depression, functional impairment and quality of life * Visit the clinic for a single session intervention including practicing the Attention Training Technique (ATT) * Complete 2 telephone calls with a researcher to discuss their use of the intervention and to complete the same questionnaires from their clinic visit, and a questionnaire about their experience of the study and intervention.

Interventions

BEHAVIORALBrief psychological intervention including attention training

Brief psychological intervention including attention training

Sponsors

King's College Hospital NHS Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 65 or below * Meet criteria for diagnosis of FCD (criteria include normal MRI results with no neurological diagnosis, and symptoms that are not explained by any other medical condition, performance at routine pre-baseline neuropsychological assessment within the service) * Not taking part in any other intervention study or trial

Exclusion criteria

* Aged above 65 years * Lack capacity to consent * MRI results not in normal range * Neurological diagnosis * Indication of severe low mood or depression (from clinical interview, routine measures) * Taking part in any other intervention study or trial

Design outcomes

Primary

MeasureTime frameDescription
Participant recruitment, feasibility and retention from baseline to follow-upFrom enrollment to follow-up 6 weeks post-intervention.• Number of participants recruited and retention rate (number and percentage of participants completing post-intervention measures) will be recorded.

Secondary

MeasureTime frameDescription
Acceptability of the study intervention at follow-upPost-intervention follow-up at 6 weeks.• At follow-up, participants will complete a questionnaire to collect information on acceptability of the study and intervention (Theoretical framework of acceptability \[TFA\] questionnaire; Sekhon et al., 2022).
Change in symptoms of depression from enrolment to post-intervention follow-upAt enrolment and at follow-up 6 weeks post-interventionParticipants will complete questionnaire at enrolment and at follow-up post-intervention: • Patient Health Questionnaire 9 (PHQ-9) (Kroenke et al., 2001)
Change in symptoms of anxiety from enrolment to post-intervention follow-upAt enrolment and at follow-up 6 weeks post-interventionParticipants will complete questionnaire at enrolment and at follow-up post-intervention: • Generalised Anxiety Disorder 7 questionnaire (GAD- 7) (Spitzer et al., 2006)
Change in functional impairment from enrolment to post-intervention follow-upAt enrolment and at follow-up 6 weeks post-interventionParticipants will complete questionnaire at enrolment and at follow-up post-intervention: • Work and Social Adjustment Scale (WSAS) (Mundt et al., 2002)
Change in quality of life from enrolment to post-intervention follow-upAt enrolment and at follow-up 6 weeks post-interventionParticipants will complete questionnaire at enrolment and at follow-up post-intervention: • EuroQol 5-Dimension 5-Level (EQ-5D-5L)(Herdman et al., 2011)
Change in self-reported cognitive symptoms from enrolment to post-intervention follow-upAt enrolment and at follow-up 6 weeks post-interventionParticipants will complete questionnaire at enrolment and at follow-up post-intervention: • The Cognitive Failures Questionnaire 2.0(Goodhew \& Edwards, 2024).

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026